| |
 |
|
Class Information
Number: 424/85.7
Name: Drug, bio-affecting and body treating compositions > Lymphokine > Interferon > Alpha or leukocyte
Description: Subject matter in which the interferon is alpha or leukocyte interferon.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7625555 |
Recombinant human interferon-like proteins |
Dec. 1, 2009 |
| 7619067 |
Evolved interferon-alpha polypeptides |
Nov. 17, 2009 |
| 7611700 |
Protease resistant modified interferon alpha polypeptides |
Nov. 3, 2009 |
| 7597884 |
Hyperglycosylated polypeptide variants and methods of use |
Oct. 6, 2009 |
| 7592010 |
Albumin fusion proteins |
Sep. 22, 2009 |
| RE40882 |
Antiviral nasal drops comprising recombinant interferon a biocompatible polymer and an antioxidant |
Aug. 25, 2009 |
| 7547436 |
Receptor specific transepithelial transport of therapeutics |
Jun. 16, 2009 |
| 7541436 |
Interferon-alpha polypeptides and conjugates |
Jun. 2, 2009 |
| 7537755 |
Interferon-alpha polypeptides and conjugates |
May. 26, 2009 |
| 7531630 |
Interferon-alpha polypeptides and conjugates |
May. 12, 2009 |
| 7504097 |
Interferon-alpha polypeptides and conjugates |
Mar. 17, 2009 |
| 7501392 |
Method of treatment of viral hepatitis C with interferon alpha 5 |
Mar. 10, 2009 |
| 7488473 |
Interferon-alpha polypeptides and conjugates |
Feb. 10, 2009 |
| 7488801 |
Interferon-alpha polypeptides and conjugates |
Feb. 10, 2009 |
| 7482149 |
Inhibition of SARS coronavirus infection with clinically approved antiviral drugs |
Jan. 27, 2009 |
| 7482014 |
Melanoma therapy |
Jan. 27, 2009 |
| 7476384 |
Death domain containing receptor 4 antibody and methods |
Jan. 13, 2009 |
| 7445774 |
Glycosylated interferon .alpha. |
Nov. 4, 2008 |
| 7431920 |
Method of treating IL-10 deficiency |
Oct. 7, 2008 |
| 7416723 |
Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases |
Aug. 26, 2008 |
| 7402305 |
Polypeptides of the IFN.alpha.-21 gene |
Jul. 22, 2008 |
| 7399464 |
Polypeptides of the IFN.alpha.-7 gene |
Jul. 15, 2008 |
| 7371372 |
Compositions comprising IMPDH inhibitors and uses thereof for treating HCV infection |
May. 13, 2008 |
| 7371819 |
Polypeptides of the IFN.alpha.-17 gene |
May. 13, 2008 |
| 7364724 |
Recombinant super-compound interferon |
Apr. 29, 2008 |
| 7358333 |
Polypeptides of the IFN.alpha.-5 gene |
Apr. 15, 2008 |
| 7338654 |
Glycosylated interferon alpha obtained from a transgenic chicken |
Mar. 4, 2008 |
| 7314613 |
Interferon-alpha polypeptides and conjugates |
Jan. 1, 2008 |
| 7311903 |
Glycosylated human interferon alpha isoform |
Dec. 25, 2007 |
| 7294332 |
Combination therapy (temozolomide and .alpha.-IFN) for advanced cancer |
Nov. 13, 2007 |
| 7270809 |
Cysteine variants of alpha interferon-2 |
Sep. 18, 2007 |
| 7232563 |
Hybrid interferon/interferon tau proteins, compositions and methods of use |
Jun. 19, 2007 |
| 7201897 |
Interferon conjugates |
Apr. 10, 2007 |
| 7189389 |
Pharmaceutical composition of human interferon-.alpha.2 and interferon .alpha.8 subtypes |
Mar. 13, 2007 |
| 7182942 |
Vaccine immunotherapy for immune suppressed patients |
Feb. 27, 2007 |
| 7175839 |
Cancer immunotherapy using allostimulated cells in a multiple sequential implantation strategy |
Feb. 13, 2007 |
| 7138376 |
Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides |
Nov. 21, 2006 |
| 7115578 |
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
Oct. 3, 2006 |
| 7067129 |
Receptor specific transepithelial transport in therapeutics |
Jun. 27, 2006 |
| 7041301 |
Interferon immunotherapy |
May. 9, 2006 |
| 7033594 |
Method of treatment using ligand-immunogen conjugates |
Apr. 25, 2006 |
| 7030086 |
Stabilized liquid polypeptide-containing pharmaceutical compositions |
Apr. 18, 2006 |
| 6995133 |
Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
Feb. 7, 2006 |
| 6991785 |
Method for administering a cytokine to the central nervous system and the lymphatic system |
Jan. 31, 2006 |
| 6987103 |
Treatment of chronic myelogenous leukmia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agents |
Jan. 17, 2006 |
| 6962695 |
Modification of interferon alpha production |
Nov. 8, 2005 |
| 6956027 |
N-terminally chemically modified protein compositions and methods |
Oct. 18, 2005 |
| 6949520 |
Methods related to immunostimulatory nucleic acid-induced interferon |
Sep. 27, 2005 |
| 6923966 |
Melanoma therapy |
Aug. 2, 2005 |
| 6924270 |
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
Aug. 2, 2005 |
|
|
|
